Page last updated: 2024-12-07

wr 33278

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

WR 33278: symmetrical disulfide of WR-1065 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID115059
SCHEMBL ID9231402
MeSH IDM0132543

Synonyms (16)

Synonym
58205-87-1
n'-[2-[2-(3-aminopropylamino)ethyldisulfanyl]ethyl]propane-1,3-diamine
phosphoric acid compound with n~1~-(2-((2-((3-aminopropyl)amino)ethyl)dithio)ethyl)-1,3-propanediamine (1:1)
wr 33278
n,n''-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine
unii-s8kc806h2t
s8kc806h2t ,
nsc 358533
1,3-propanediamine, n,n''-(dithiodi-2,1-ethanediyl)bis-
wr-33278
1,3-propanediamine, n1,n1'-(dithiodi-2,1-ethanediyl)bis-
n-[2-[2-(3-aminopropylamino)ethyldisulfanyl]ethyl]propane-1,3-diamine
bis[2-(3-aminopropylamino)ethyl]disulfide
SCHEMBL9231402
n,n'-bis-(3-amino-propyl)cystamine
Q27289053

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic properties of WR-2721 were investigated in 13 cancer patients given a 150 mg/M2 intravenous bolus dose of the drug."( Human pharmacokinetics of WR-2721.
Bonner, HS; Glover, DJ; Kligerman, MM; Norfleet, AL; Shaw, LM; Turrisi, AT; Weiler, C, 1986
)
0.27
" Validated analytic methodology to measure parent drug and pharmacologically active metabolites and pharmacokinetic studies are essential to the efficient performance and analysis of clinical studies."( Pharmacokinetic profile of amifostine.
Bonner, H; Lieberman, R; Shaw, LM, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (15.00)18.7374
1990's13 (65.00)18.2507
2000's4 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.75 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]